Insights on Recent Trades: 3M, Visa, Medtronic & More
3M Company: Performance Highlights
On the latest episode of CNBC's "Halftime Report Final Trades," Joshua Brown from Ritholtz Wealth Management highlighted the performance of 3M Company (MMM). The company has shown notable gains recently, indicating a positive sentiment among investors.
Analyst Coverage and Rating
Recently, Morgan Stanley analyst Chris Snyder initiated coverage on 3M, recommending a cautious approach with an Underweight rating. The analyst set a price target of $125 for the stock, creating a point of interest for investors monitoring its performance closely.
Visa Inc: Analyst Perspectives
Another stock on the radar is Visa Inc (V), which received a favorable mention from Kevin Simpson of Capital Wealth Planning. Visa's potential has garnered attention from analysts and investors alike.
Recent Analyst Initiatives
On September 4, Compass Point analyst Dominick Gabriele initiated coverage on Visa with a Buy rating. His analysis suggests a steady outlook for Visa, with an ambitious price target set at $319, reflecting confidence in the company's growth trajectory.
Medtronic plc: Strong Dividend Yield
Medtronic plc (MDT), presented by Jenny Van Leeuwen Harrington from Gilman Hill Asset Management, boasts a 3% dividend yield. This makes it an attractive option for income-focused investors.
Quarterly Performance Review
Medtronic has recently reported impressive financial results for its first quarter, exceeding expectations. With $7.92 billion in sales for Q1 2025, the company outperformed the anticipated $7.89 billion in revenue. The adjusted EPS of $1.23 also surpassed the consensus estimate of $1.20, showcasing Medtronic's strong operational performance and growth, with a 2.8% year-over-year increase in reported revenue.
Invesco S&P 500 High Dividend Low Volatility ETF
In a strategic move, Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) was named as a final trade by Liz Young of SoFi. This ETF is recognized for its stability and potential for income generation, appealing to various investors.
Market Activity Summary
As of Tuesday's market session, several key stocks noted significant price movements:
- 3M saw a 1.3% gain, closing at $130.09.
- Visa shares decreased slightly by 0.1%, settling at $285.34.
- Medtronic experienced a modest rise of 0.4%, closing at $90.99.
- The Invesco S&P 500 High Dividend Low Volatility ETF rose by 0.2% during the same session.
Frequently Asked Questions
What stocks were discussed in CNBC's Final Trades?
The stocks discussed included 3M, Visa, Medtronic, and the Invesco S&P 500 High Dividend Low Volatility ETF.
What is the recent rating for 3M Company?
3M was given an Underweight rating by Morgan Stanley with a price target of $125.
How did Medtronic perform in its latest quarterly report?
Medtronic reported $7.92 billion in sales, surpassing expectations and showing a strong year-over-year growth.
What dividend yield does Medtronic offer?
Medtronic offers a dividend yield of 3%, which is appealing to income-focused investors.
Who initiated coverage on Visa, and what was the rating?
Dominick Gabriele from Compass Point initiated coverage on Visa with a Buy rating and a target price of $319.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.